Multiple Myeloma Stocks List

Recent Signals

Date Stock Signal Type
2020-08-04 ADAP Bollinger Band Squeeze Range Contraction
2020-08-04 ADAP Narrow Range Bar Range Contraction
2020-08-04 BMY 50 DMA Support Bullish
2020-08-04 BMY 20 DMA Support Bullish
2020-08-04 BMY 180 Bullish Setup Bullish Swing Setup
2020-08-04 BMY MACD Bullish Signal Line Cross Bullish
2020-08-04 BMY Bollinger Band Squeeze Range Contraction
2020-08-04 CALA Lower Bollinger Band Walk Weakness
2020-08-04 CASI Stochastic Reached Oversold Weakness
2020-08-04 CASI Volume Surge Other
2020-08-04 CGEN MACD Bullish Centerline Cross Bullish
2020-08-04 CGEN MACD Bullish Signal Line Cross Bullish
2020-08-04 CLLS 20 DMA Support Bullish
2020-08-04 CLLS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-04 CLLS MACD Bullish Signal Line Cross Bullish
2020-08-04 CLLS Bollinger Band Squeeze Range Contraction
2020-08-04 CLLS Fell Below 50 DMA Bearish
2020-08-04 CNST Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-04 CNST Fell Below 20 DMA Bearish
2020-08-04 CNST NR7 Range Contraction
2020-08-04 CRIS Stochastic Buy Signal Bullish
2020-08-04 CRIS Crossed Above 20 DMA Bullish
2020-08-04 CRIS Crossed Above 200 DMA Bullish
2020-08-04 GMAB Bollinger Band Squeeze Range Contraction
2020-08-04 GMAB Fell Below 20 DMA Bearish
2020-08-04 GMAB NR7 Range Contraction
2020-08-04 GMAB Narrow Range Bar Range Contraction
2020-08-04 IMGN 180 Bearish Setup Bearish Swing Setup
2020-08-04 IMGN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-04 IMGN Fell Below 200 DMA Bearish
2020-08-04 IMGN Stochastic Reached Oversold Weakness
2020-08-04 LGND 20 DMA Resistance Bearish
2020-08-04 LGND New Uptrend Bullish
2020-08-04 STRO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-04 STRO Crossed Above 20 DMA Bullish
2020-08-04 STRO Narrow Range Bar Range Contraction
2020-08-04 STRO Bollinger Band Squeeze Range Contraction
2020-08-04 STRO MACD Bullish Signal Line Cross Bullish
2020-08-04 XTLB Calm After Storm Range Contraction

Multiple myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. Often, no symptoms are noticed initially. When advanced, bone pain, bleeding, frequent infections, and anemia may occur. Complications may include amyloidosis.The cause is unknown. Risk factors include obesity, radiation exposure, family history, and certain chemicals. The underlying mechanism involves abnormal plasma cells producing abnormal antibodies which can cause kidney problems and overly thick blood. The plasma cells can also form a mass in the bone marrow or soft tissue. When only one mass is present, it is known as a plasmacytoma, while more than one is known as multiple myeloma. Multiple myeloma is diagnosed based on blood or urine tests finding abnormal antibodies, bone marrow biopsy finding cancerous plasma cells, and medical imaging finding bone lesions. Another common finding is high blood calcium levels.Multiple myeloma is considered treatable, but generally incurable. Remissions may be brought about with steroids, chemotherapy, targeted therapy, and stem cell transplant. Bisphosphonates and radiation therapy are sometimes used to reduce pain from bone lesions.Globally, multiple myeloma affected 488,000 people and resulted in 101,100 deaths in 2015. In the United States, it develops in 6.5 per 100,000 people per year and 0.7% of people are affected at some point in their lives. It usually occurs around the age of 61 and is more common in men than women. It is uncommon before the age of 40. Without treatment, typical survival is seven months. With current treatments, survival is usually 4–5 years. This gives a five-year survival rate around 49%. The word myeloma is from the Greek myelo- meaning "marrow" and -oma meaning "tumor".

More about Multiple Myeloma